Abstract
Porphyrins form extremely stable chelates with Cu2+. Two copper radionuclides, 67Cu and 64Cu, have attractive nuclear decay properties for use in nuclear medicine applications. We have investigated the use of radiocopper-labeled porphyrins for localization in inflamed tissue and for attachment to antibodies for tumor imaging and therapy. We have examined the biodistribution of a 67Cu labeled porphyrin, [5,10,15,20-tetrakis(4-carboxyphenyl) porphinato [67Cu] copper (II)], 67CuTCPP. The 67CuTCPP was intravenously injected into the tail vein of Fischer F344 male rats. The kidneys, liver, and spleen localize the greatest amounts of 67CuTCPP. The elimination of 67CuTCPP from the body is described by a normal exponential decay curve with a biological half-life of 108 hours and an effective half-life of 32 hours. We have also examined the biodistribution of 5-(4-carboxyphenyl)-10,15,20-tris(4-sulfophenyl) porphinato [67Cu] copper (II) anti-Thy 1.2 antibody conjugates in normal and tumor-bearing male AKR/J mice. The liver, kidney, and tumor have the highest uptake of the 67Cu labeled antibody conjugate. In all 67Cu labeled compounds studied, the blood clearance was rapid and the bone concentration of the radiolabeled species was low.
To whom correspondences should be addressed
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literature Cited
Armitage, N. C., Perkins, A. C., Pimm, M. V., Wastie, M. L., Baldwin, R. W., Hardcastle, J. D., 1985, Imaging of primary and metastatic colorectal cancer using an 111In-labelled antitumour monoclonal antibody (791T/36), Nucl. Med. Commun., 6:623.
Browne, E., Kairiki, J. M., Doebler, R. E.,1978, “Table of Isotopes, 7th Edition,” John Wiley, New York, pp. 197–198,211–212.
Bradford, M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem., 72:248.
Buchler, J. W., 1975, Static coordination chemistry of metalloporphyrins, in: “Porphyrins and Metalloporphyrins,” K. M. Smith, ed., Elsevier Scientific, New York, pp. 157–231.
Clelland, C. O., Giles, D. D., Farley, T. D., Gee, Q. Wright, J. R., 1986, The intravenous distribution of a radiolabeled potentially useful cluster ion of copper and penicillamine, Physiol. Chem. Phys. Med., 18:31.
Cole, D. C., Mercer-Smith, J. A., Norman, J. K., Bullington, K. P., Roberts, J. C., Lavallee, D. K., 1989, Copper-67 labeled porphyrin localization in inflamed tissues, in “Copper Nutrition and Bioavailability,” C. Kies, ed., Plenum Press, New York, in press.
Cole, W. D., DeNardo, S. J., Meares, C. R., McCall, M. J., DeNardo, G. L., Epstein, A. L., O’Brien, H. A., Moi, M. K., 1987, Comparative serum stability of radiochelates for antibody radiopharmaceuticals, J. Nucl. Med., 28:83.
Dougherty, T. J., Lawrence, G., Kaufman, J. H., Boyle, D., Weishaupt, K. R., Goldfarb, A., 1979, Photoradiation in the treatment of recurrent breast carcinoma, J. Natl. Cancer Inst., 62:231.
Eckelman, W. C. Paik, C. H., 1989, Labeling antibodies with metals using bifunctional chelates, in: “Antibodies in Radiodiagnosis and Therapy,” M. R. Zalutsky, ed., CRC Press, Boca Raton, Florida, pp. 103–128.
El-Far, M. A. Pimstone, N. R., 1986, Selective in vivo tumor localization of uroporphyrin isomer I in mouse mammary carcinoma: Superiority over other porphyrins in a comparative study, Cancer Res., 46:4390.
Fawwaz, R. A., 1978, Systematically administered compounds for lymphatic ablation, in: “Therapy in Nuclear Medicine,” R. P. Spencer, ed., Grune and Stratton, New York, pp. 193–204.
Fawwaz, R. A., Frye, F., Laughman, W. D., 1974, Survival of skin homographs in dogs injected with 109Pd porphyrin, J. Nucl. Med., 15:991.
Fawwaz, R. A., Hemphill, W., Winchell, H. S., 1971, Potential use of Pd-109 porphyrin complexes for selective lymphatic ablation, J. Nucl. Med., 12:231.
Fawwaz, R. A., Winchell, H. S., Frye, F., 1969, Localization of Co-58 and Zn-65 hematoporphyrin complexes in canine lymph nodes, J. Nucl. Med., 10:581.
Foster, N., Woo, D. V., Kaltovich, F., Emrich, J., Ljungquist, C, 1985, Delineation of a transplanted malignant melanoma with In-111-labeled porphyrin, J. Nucl. Med., 26:756.
Hambright, P., Fawwaz, R., Valk, P., McRae, J., Bearden, A. J., 1975, The distribution of various water soluble radioactive metalloporphyrins in tumour-bearing mice, Bioinorg. Chem., 5:87.
Hardy, M. A., Fawwaz, R. A., Oluwole, S., Todd, G., Nowygrod, R., Reemtsma, K., 1979, Selective lymphoid irradiation. I. An approach to transplantation, Surgery, 86:194.
Hopf, F. R. Whitten, D. G., 1975, Photochemistry of porphyrins and metalloporphyrins, in: “Porphyrins and Metalloporphyrins,” K. M. Smith, ed., Elsevier Scientific, New York, pp. 667–700.
Keenan, A. M., Harbert, J. C., Larson, S. M., 1985, Monoclonal antibodies in nuclear medicine, J. Nucl. Med., 26:531.
Kessel, D., 1984, Hematoporphyrin and HPD: Photophysics, photochemistry, and phototherapy, Photochem. Photobiol., 59:851.
Lavallee, D., White, A., Diaz, A., Battioni, J., Mansuy, D., 1986, Efficient metalloporphyrin synthesis under mild conditions using N-benzyl porphyrins, Tet. Lett., 27:3521.
Ledbetter, J. A., Rouse, R. V., Miclem, H. S., Herzenberg, L. A., 1980, T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens, J. Exp. Med., 52:280.
Maziere, B., Stulzaft, O., Verret, M. M., Comar, D., Syrota, A., 1983, [55Co]- and [64Cu]-DTPA: New radiopharmaceuticals for quantitative tomocisternography, Int. J. Appl. Radiat. Isot., 34:595.
Mercer-Smith, J. A., Roberts, J. C., Figard, S. D., Lavallee, D. K., 1988, The development of copper-67 labeled porphyrin-antibody conjugates, in: “Antibody-Mediated Delivery Systems,” J. D. Rodwell, ed., Marcel Dekker, New York, pp. 317–352.
Nunn, A. D., 1979, The kinetics of incorporation of In- 111 into meso-tetraphenylporphine, J. Radioanal. Chem., 53:291.
Parr, G. R. Pasternak, R. F., 1977, The interaction of some water-soluble porphyrins and metalloporphyrins with human serum albumin, Bioinorg. Chem., 7:277.
Peters, T, 1977, Serum albumin: Recent progress in the understanding of its structure and biosynthesis, Clin. Chem., 23:5.
Prout Jr., G. R., Lin, C-W., Benson Jr., R., Nseyo, U. O., Daly, J. J., Griffin, P. P., Kinsey, J., Tian, M., Lao, Y., Mian, Y., Chen, X., Ren, E., Qiao, S., 1987, Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder, N. Engl. J. Med., 377:1251.
Raman, S., Pinajian, J. J., 1969, Decay of 67Cu, Nucl. Phys., A131:393.
Reftmann, J. P., Morliere, P., Goldstein, S. Santus, R., Dubertret, L. Lagrange, D., 1984, Interaction of human serum low density lipoprotein with porphyrins: a spectroscopic and photochemical study, Photochem. Photobiol., 40:121.
Roberts, J. C., Figard, S. D., Mercer-Smith, J. A., Svitra, Z. V., Anderson, W. L., Lavallee, D. K., 1987, Preparation and characterization of copper-67 porphyrin-antibody conjugates, J. Immunol. Meth., 105:153.
Roberts, J. C., Newmyer, S. L., Mercer-Smith, J. A., Schreyer, S. A., Lavallee, D. K., 1989, Labeling antibodies with copper radionuclides using N-4-nitrobenzyl-5-(4-carboxyphenyl)-10,15,20-tris(4-sulfophenyl) porphine, Int. J. Appl. Radiat. Isot., in press.
Robinson Jr., G. D., Alavi, A., Vaum, R., Staum, M., 1986, Imaging of lymph node uptake after intravenous administration of indium-111 metalloporphyrins, J. Nucl. Med., 27:239.
Ruben, S. Kamen, M. D., Allen, M. B., Nahinsky, P., 1942, Some exchange experiments with radioactive tracers, J. Am. Chem. Soc., 64:2291.
Sands, H. Gallagher, B. ML, 1989, Physiological, pharmacological, and immunological aspects of antibody targeting, in: “Antibodies in Radiodiagnosis and Therapy,” M. R. Zalutsky, ed., CRC Press, Boca Raton, Florida, pp. 129–151.
Taylor Jr., A., Milton, W., Eyre, H., Christian, P., Wu, F., Hagan, P., Alazraki, N. Datz, F. L., Unger, M., 1988, Radioimmunodetection of human melanoma with indium-111-labeled monoclonal antibody, J. Nucl. Med., 29:329.
Vaum, R., Heindel, N. D„ Burns, H. D., Emrich, J., Foster, N., 1982, Synthesis and evaluation of an In-111-labeled porphyrin for lymph node imaging, J. Pharm. Sci., 71:1223.
Wang, T S. T., Fawwaz, R. A., Tomashefsky, P., 1981, Metalloporphyrin derivatives: Structure-localization properties, in: “Radiopharmaceuticals: Structure-Activity Relationships,” R. P. Spencer, ed., Grune and Stratton, New York, pp. 225–249.
Wessels, B. W., Rogus, R. D., 1984, Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies, Med. Phys., 11:638.
Yokoyama, K., Carrasquillo, J. A., Chang, A. E., Colcher, D., Roselli, M., Sugarbaker, P., Sindelar, W., Reynolds, J. C., Perentesis, P., Gansow, O. A., Francis, B., Adams, R., Finn, R., Schlom, F., Larson, S. M., 1989, Differences in biodistribution of indium-111- and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer, J. Nucl. Med., 30:320.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Mercer-Smith, J.A., Cole, D.A., Roberts, J.C., Lewis, D., Behr, M.J., Lavallee, D.K. (1989). The Biodistribution of Radiocopper-Labeled Compounds. In: Kies, C. (eds) Copper Bioavailability and Metabolism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0537-8_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0537-8_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7855-9
Online ISBN: 978-1-4613-0537-8
eBook Packages: Springer Book Archive